Androgen hydroxylation catalysed by Chinese hamster fibroblast SD 1 cells, which stably express cytochrome P-450 form PB-4, the rat P450IIBI gene product, was assessed and compared to that catalysed by purified cytochrome P-450 PB-4 isolated from rat liver. SDI cell homogenates catalysed the NADPHdependent hydroxylation of androstenedione and testosterone with a regioselectivity very similar to that purified by P-450 PB-4 (16,8)-hydroxylation/ 16a-hydroxylation = 6.0-6.8 for androstenedione; 16,/ 16a = 0.9 for testosterone). Homogenates prepared from the parental cell line V79, which does not express detectable levels of P-450 PB-4 or any other cytochrome P-450, exhibited no androgen 16/3-or 16a-hydroxylase activity. The hydroxylase activities catalysed by the SD1 cell homogenate were selectively and quantitatively inhibited ( > 90°/) by a monoclonal antibody to P-450 PB-4 at a level of antibody (40 pmol of antibody binding sites/mg of SD I homogenate) that closely corresponds to the P-450 PB-4 content of the cells (48 pmol of PB-4/mg of SDI homogenate). Fractionation of cell homogenates into cytosol and microsomes revealed that the P-450 PB-4-mediated activities are associated with the membrane fraction. Although the P-450 PB-4-specific content of the SD 1 microsomes was 150 of that present in phenobarbitalinduced rat liver microsomes, the P-450 PB-4-dependent androstenedione 16,8-hydroxylase activity of the SD1 membrane fraction was only 2-3 00 of that present in the liver microsomes. This activity could be stimulated several-fold, however, by supplementation of SDI microsomes with purified rat NADPH P-450 reductase. These studies establish that a single P-450 gene product (IIBI) can account for the hydroxylation of androgen substrates at multiple sites, and suggest that SDI cells can be used to assess the catalytic specificity of P-450 PB-4 with other substrates as well.
INTRODUCTION
Mammalian cytochrome P-450 cDNAs have been studied using a variety of expression systems, including transformed yeast cells and Chinese hamster fibroblasts [1, 2] , which provide for stable expression of the P-450s, in addition to transfected cos-l cells [3] and vacciniavirus-infected mouse and human cells [4] , where transient P-450 expression is achieved. These expression systems have been useful for (1) confirming the identities of cloned cDNAs (e.g. [5] [6] [7] ), (2) identification of functional domains and essential amino acids by site-directed mutagenesis and construction of chimaeric P-450s [8, 9] , (3) characterization of steroidogenic pathways requiring the participation of multiple P-450 enzymes [10] and (4) development of P-450-containing cell lines that can be used for bioactivation and mutagenicity testing [2] . P-450 expression systems also provide the opportunity to characterize the enzymic activities of individual P-450 enzymes that may otherwise be difficult to study by conventional methods, owing to, for example, their low endogenous expression in available tissues, their copurification with closely-related P-450 forms or their denaturation during the course of purification.
Rat hepatic cytochrome P-450 form PB-4 (gene IIBI) is a phenobarbital-inducible P-450 enzyme that exhibits high activity and broad specificity for the oxidative metabolism of drugs, carcinogens and other xenobiotics 111 -13] . (Other commonly used designations for P-450 PB-4 include P-450b [12] , P-450 PB-B [13] and PBRLM5 [17] , among others.) When assayed with steroid hormone substrates, this P-450 form exhibits a high selectivity for hydroxylation of the steroid D-ring [14, 15] . Structureactivity analyses have established that the nature of the steroid's C17 substituent can markedly affect the stereoselectivity of the cytochrome for hydroxylation at C16. Thus, with testosterone as substrate (C17 substituent = ,/-hydroxyl group) a 16/,/16a ratio of -0.9 is observed, whereas with androstenedione (C17 substituent = oxo group) a 16/1/ 16ac ratio of -13-15 is seen (for review see [16] ). The consistency of these hydroxylation patterns in equivalent preparations of this cytochrome subsequently described by other laboratories (e.g. [17] [18] [19] ) and the ability of monoclonal antibodies to inhibit to a similar extent each of the multiple hydroxylation reactions catalysed by purified P-450 PB-4 [20] argues that these multiple hydroxylation activities are inherent to the P-450 PB-4 preparations remains unknown. These and related questions are addressed in the present study, which characterizes the oxidative metabolism of androstenedione and testosterone catalysed by the Chinese hamster fibroblast cell line SD 1 [2] , which stably expresses the P450IIBI gene product P-450 PB-4.
MATERIALS AND METHODS

Cells
V79 Chinese hamster fibroblast (parental) cells and SD1 cells that were transfected with P450IIB1 cDNA and stably express P-450 PB-4 protein were prepared and grown as described by Doehmer et al. [2] . Cell pellets were harvested and frozen at -80°C until use. Cells were disrupted by sonication in 0.1 M-potassium phosphate buffer, pH 7.4, containing I mM-EDTA and 20 00 (v/v) glycerol (2 x 108 cells/ml) on ice for 4 x 5 s using a Branson sonicator (Model 200; B15 microtip with pulse sonication at an output control of 5 at 4000 duty cycle). Particulate matter was removed by centrifugation for 7 min at 12000 g and a membrane fraction ('microsomes') was pelleted by centrifugation for 45 min at 100000 g. Fig. 2a ). Product analysis by t.l.c. and comparison with authentic hydroxysteroid standards was carried out as described previously [14, 22] . Where indicated, complete assay mixtures minus NADPH were preincubated (30 min at 20-22°C ) in the presence of inhibitory monoclonal antibody to P-450 PB-4 (MAb B4, clone 4-29-5; [20, 23] ). The antibody was purified from ascites fluid by the method of McKinney & Parkinson [24] prior to use to minimize the non-specific effects that ascites fluid can have on P-450-catalysed reactions. Where indicated, assays of cell fractions were supplemented with NADPH P-450 reductase, which had been purified to apparent homogeneity from phenobarbital-induced rabbit liver as described elsewhere [I1].
Other methods
Western blotting with polyclonal anti-(P-450 PB-4) antibodies [22] and immunoquantification of P-450 PB-4 levels in SDI cell fractions were carried out using methods detailed elsewhere [25] . NADPH P-450 reductase activity was assayed at 30°C in 0.3 M-potassium phosphate buffer, pH 7.7, by the reduction of cytochrome c (monitored at 550 nm; e 21 mM-'-cm-') ( both the SD I cytosolic fraction and the V79 cell homogenate, indicating that the reduction of androstenedione to testosterone is an activity that is independent of the expression of P-450 PB-4 in the SDI cells. Monoclonal antibody to P-450 PB-4 inhibited SDIcatalysed androstenedione 16,/-and 16a-hydroxylation by > 9000 without affecting the rate of testosterone formation (Fig. 2b) . This further supports the conclusion that the hydroxylase activities but not the oxidoreductase activity is P-450 PB-4-dependent. The P-450 PB-4-specific content and androstenedione hydroxylase activities of the SD1 cells were both enriched about 2-fold upon preparation of a microsomal fraction from the cell homogenate (Table 2) ; this is consistent with a localization of the P-450 enzyme to the endoplasmic reticulum of these cells. The 16,/ 16ac hydroxy product ratio was similar for both cell fractions (ratio = 6.0-6.8; Table 2 ) but was -2-fold lower than that exhibited by purified P-450 PB-4 when assayed in a reconstituted system containing dilauroylphosphatidylcholine (16,//16a = 13-15 [14] [15] [16] (Table 2) ], which resembles that found by Platt et al. [26] , is essentially the same as that reported for the purified cytochrome (16,//16a = 0.8-0.9 [14, 15] ). These observations establish that the previously-described androgen hydroxylase profiles of isolated preparations of P-450 PB-4 accurately reflect the catalytic specificity of a single P-450 form. Table 2 also expresses the P-450 PB-4-dependent hydroxylase activities of the SD I cell fractions as apparent turnover numbers (mol of activity/min per mol of P-450 PB-4). These activity values (1.7-2.0 min-' for androstenedione as substrate and 0.2 min-1 for testosterone as substrate) are lower than those exhibited by rat liver microsomal P-450 PB-4 (7.6 min-1 for P-450 PB-4-dependent androstenedione 16,/-hydroxylation catalysed by phenobarbital-induced rat liver microsomes [16] ), and substantially lower than the activities exhibited by the purified cytochrome (apparent turnover = 6 min-1 for testosterone and 34 min-1 for androstenedione [16] ).
It is known from previous studies that a suboptimal Immunoquantification of P-450 PB-4 levels and enzymic activity assays were carried out as described in the Materials and methods section. Hydroxylation at several other potential sites (e.g. 6,/-hydroxylation, 7az-hydroxylation) was shown to proceed at < 2 pmol/min per mg of SDI microsomes for both steroid substrates. Rates of androstenedione reduction to testosterone (50 and 17 pmol/min per mg for the homogenate and microsomal fraction, respectively) are not included since this activity is not P-450 PB-4-dependent and is primarily cytosolic (see Table 1 ). Although 80-95 % of the testosterone 16,/ and 16a hydroxylase activities of the SDI microsomal fraction were inhibited by antibody to P-450 PB-4, only 300% of the androstenedione formation activity was inhibitible by the antibody (results not shown). This suggests that a portion of this activity is P-450 PB-4-independent. content of NADPH P-450 reductase in liver microsomes is a major contributing factor to the lower turnover numbers exhibited by microsomal P-450s as compared to purified P-450 forms assayed in reconstituted systems (e.g. [27] ). The NADPH P-450 reductase activity in the SD1 microsomal fraction was therefore assayed and compared to that of liver microsomes. P-450 reductasecatalysed cytochrome c reduction rates were found to be very low for the SD1 microsomes, i.e. 17. number (with no significant change in the 16,3/ 16a hydroxy product ratio) was achieved by carrying out the hydroxylase assays in the presence of exogenous purified rat liver NADPH P-450 reductase (Fig. 3) . Although the highest level of exogenous P-450 reductase used in this experiment (6.6 units of P-450 reductase/mg of SD1 membrane fraction) corresponds to a P-450 reductase/P-450 PB-4 ratio of 18: 1, the turnover number of the SD1 microsomal P-450 PB-4 still does not appear to be saturated (Fig. 3) . This apparent requirement for even higher P-450 reductase levels may reflect a low efficiency of incorporation of the exogenous P-450 reductase into the SD1 membrane fraction.
In summary, the present studies establish that SD1 cells hydroxylate androstenedione and testosterone with a regioselectivity and stereospecificity close to that exhibited by purified preparations of rat hepatic P-450 form PB-4. This suggests that these cells can be utilized to reliably assess the catalytic specificity of P-450 PB-4 with other substrates as well. While NADPH P-450 reductase is expressed constitutively in the SD1 cells and is capable of electron transfer to the expressed P-450 cytochrome, the endogenous level of this flavoprotein reductase is a limiting factor for the expression of mono-oxygenase activity. Although this limitation can be partially overcome when assays of SD1 microsomes are carried out in vitro in the presence of exogenous purified P-450 reductase, an even more effective stimulation of P-450-dependent mono-oxygenase activity might be achieved by transfection of the SD 1 cells with the cDNA for NADPH P-450 reductase [28] . This could lead to an increased sensitivity of these cells for metabolism and mutagenicity studies involving P-450 PB-4-dependent reactions.
